NCT04405154 A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT04402073 Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma Status TERMINATED Phase PHASE2
NCT04392622 d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC Status RECRUITING Phase PHASE1
NCT04390958 Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT04389073 Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine Status UNKNOWN Phase PHASE2
NCT04383743 Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE2
NCT04380636 Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04379596 Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03) Status RECRUITING Phase PHASE2
NCT04372927 ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy Status TERMINATED Phase PHASE2
NCT04369937 HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT04367311 Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04361409 Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE1
NCT04356170 Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma Status COMPLETED Phase PHASE2
NCT04351555 A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04329494 PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer Status RECRUITING Phase PHASE1
NCT04328844 A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04311762 Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04297267 A Study to Evaluate Gemcitabine Plus Cisplatin in the Treatment of TNBC Patients Following Neoadjuvant Chemotherapy Status UNKNOWN Phase PHASE2
NCT04287894 Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment Status TERMINATED Phase PHASE1